Every 10-Q that PROTO LABS, INC. (PRLB) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow PRLB and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full PRLB filings page.
Proto Labs, Inc. reported stronger results for the quarter and six months ended June 30, 2026. Second‑quarter revenue was $149,341 (in thousands), up 10.6% year over year, with net income of $9,152 (in thousands) and diluted EPS of $0.37, up from $0.18 a year earlier.
Growth was led by CNC Machining and Injection Molding, while 3D Printing revenue declined slightly. Gross margin improved to 46.4% from 44.3%, and revenue per customer contact rose 16.7% even as contacts fell 5.3%. For the first half of 2026, revenue reached $288,677 (in thousands) and net income $17,263 (in thousands). Operating cash flow increased to $32,978 (in thousands), and cash and cash equivalents were $127,918 (in thousands) at June 30, 2026, alongside ongoing share repurchases and restructuring and German facility exit costs recorded in 2026.
Proto Labs, Inc. delivered stronger quarterly performance, with revenue rising to $139.3M from $126.2M, driven mainly by CNC machining and solid growth in both U.S. and European operations. Gross margin improved to 45.6%, reflecting higher volumes and pricing.
Net income more than doubled to $8.1M, with diluted EPS increasing to $0.33. Operating cash flow was $17.5M, and cash and cash equivalents grew to $124.0M, giving the company ample liquidity while it continues to invest in capacity, technology and stock-based incentive programs.
Proto Labs (PRLB) reported Q3 2025 results. Revenue rose to $135.366M from $125.619M (up 7.8%). Diluted EPS was $0.30 versus $0.29 a year ago. Gross margin was 45.3% compared with 45.6% last year as higher volumes were offset by increased personnel and production costs. Operating income was $8.810M and net income was $7.216M.
Growth was led by the U.S. segment, where revenue increased 9.8% to $109.361M, while Europe was essentially flat at $26.005M. By product line, CNC Machining grew 18.2% to $63.043M, Injection Molding rose 2.0% to $47.770M, Sheet Metal increased 13.9% to $4.262M, and 3D Printing declined 6.3% to $20.082M. The company served 21,252 customer contacts in Q3 (down 5.6%), while revenue per contact rose 14.1%.
Year-to-date revenue reached $396.634M (up 4.6%). Cash and cash equivalents were $104.422M as of September 30, 2025. Operating cash flow for the first nine months was $58.053M. The company repurchased $36.732M of common stock year-to-date. Shares outstanding were 23,678,745 as of October 28, 2025.